The FDA's acceptance of the drug hinged on a trial involving 722 breast cancer patients with advanced tumors.
2
目的研究新辅助化疗在中晚期乳腺癌保乳治疗中的应用价值。
Objective To study the value of pre-operative chemotherapy combined with breast conservation surgery for the treatment of middle-advanced breast cancer.
点击反馈